Results 21 to 30 of about 71,226 (307)

Endothelin and restenosis [PDF]

open access: yesCardiovascular Research, 1998
Time for primary review 31 days Percutaneous transluminal angioplasty (PTCA) was first introduced into the therapy of patients with coronary artery stenosis in the late seventies [1]. In the two decades since, this method has become standard therapy for patients suffering from all forms of coronary artery disease.
Klaus Münter, Michael Kirchengast
openaire   +3 more sources

Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. [PDF]

open access: yes, 2009
Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents. A variety of antibodies and transgenic and knockout strains are available
Deuse, Tobias   +3 more
core   +2 more sources

Predictors of In-Stent Restenosis [PDF]

open access: yesAngiology, 2018
Abstract Not ...
Mehmet Kadri Akboga, Samet Yilmaz
openaire   +4 more sources

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

open access: yes, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger   +5 more
core   +2 more sources

Restenosis and Therapy

open access: yesInternational Journal of Vascular Medicine, 2012
The vascular disease involves imbalanced function of the blood vessels. Risk factors playing a role in development of impaired vessel functions will be briefly discussed. In ischemia/reperfusion (I/R), ischemic hypoxia is one of the cardinal risk factors of restenosis. Various insults are shown to initiate the phenotype switch of VSMCs.
Denes L   +2 more
openaire   +5 more sources

Prosthetic bypass for restenosis after endarterectomy or stenting of the carotid artery [PDF]

open access: yes, 2017
OBJECTIVE: The objective of this study was to evaluate the results of prosthetic carotid bypass (PCB) with polytetrafluoroethylene (PTFE) grafts as an alternative to carotid endarterectomy (CEA) in treatment of restenosis after CEA or carotid artery ...
Belmonte, Romain   +5 more
core   +1 more source

Rupture of the arterial wall causes deflection in pressure time course during ex vivo balloon angioplasty [PDF]

open access: yes, 1997
A relation between restenosis and arterial lesions resulting from balloon angioplasty has been suggested in literature. Nevertheless, it is unclear to what extent angioplasty-induced arterial wall lesions contribute to the occurrence of restenosis.
Boom, Herman B.K.   +4 more
core   +3 more sources

Platelets and restenosis

open access: yesJournal of the American College of Cardiology, 2000
Restenosis is currently the major limitation of percutaneous transluminal coronary angioplasty (PTCA). Factors such as elastic recoil, migration of vascular smooth muscle cells from media to intima, neointimal proliferation and vascular remodeling underly the restenotic process. Presently there is no effective therapy available for restenosis. The role
Baskaran Chandrasekar   +1 more
openaire   +2 more sources

The preoperative triglyceride-glucose index has a positive effect on predicting the risk of short-term restenosis after carotid artery stenting: a retrospective cohort study

open access: yesFrontiers in Neurology, 2023
BackgroundIncreasing evidence suggests that insulin resistance is linked to cardiovascular disease and atherosclerosis. The triglyceride–glucose (TyG) index has proven to be a convincing marker to quantitatively evaluate insulin resistance.
Shan-shan Zhao   +4 more
doaj   +1 more source

Day‐to‐day fasting plasma glucose variability on the short‐term prognosis of ST‐segment elevation myocardial infarction: A retrospective cohort study

open access: yesClinical Cardiology, Volume 45, Issue 12, Page 1246-1254, December 2022., 2022
Abstract Background and Hypothesis Glycemic variability in one fact that explain the differences in cardiovascular outcomes. The short‐term fasting plasma glucose (FPG) variability may have an on major adverse cardiovascular events (MACE) in type 2 diabetes mellitus (T2DM) patients with ST‐segment elevation myocardial infarction (STEMI).
Ming Yi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy